Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer | OncLive

Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

February 21, 2020

Christina Tan, MD, MPH, discusses the potential impact of the novel coronavirus on patients with cancer.

Christina Tan, MD, MPH, state epidemiologist, assistant commissioner, New Jersey Department of Health, discusses the potential impact of the novel coronavirus (COVID-19) on patients with cancer. The CDC just stated the name of this new strain is COVID-19.

Though many questions remain regarding COVID-19, individuals with weakened immune systems appear to be at greater risk of developing complications associated with COVID-19, says Tan. Individuals who fall into this category include those with cancer, cardiac or lung disease, and women who are pregnant.

Additionally, influenza poses a heightened threat to these individuals, says Tan.

Hygienic practices like frequent hand washing, covering one’s coughs and sneezes, staying home if unwell, and contacting a healthcare provider if feeling sick may prevent the spread of these diseases, says Tan. Immunocompromised individuals should also be advised to get a flu shot to protect themselves against some of the most common flu strains.


x